close
close
migores1

Shares of Bristol-Myers Squibb rose on approval of schizophrenia drug

Shares of Bristol-Myers Squibb rose on approval of schizophrenia drug

Shares of Bristol-Myers Squibb rose in premarket trading on Friday after the Food and Drug Administration approved a schizophrenia drug.

Related Articles

Back to top button